Solara Active Pharma Sciences Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
SOLARA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Solara Active Pharma Sciences has submitted its yearly disclosure under SEBI's Regulation 31(4) for the financial year ended March 31, 2025. The disclosure was filed by Pronomz Ventures LLP on behalf of the Promoters and Promoter Group. It states that the promoters have not created any new encumbrance (pledge, lien, or similar charge) on their shareholding in the company during the year, apart from what was already reported earlier. This is a routine annual filing confirming the status of pledged or encumbered promoter shares.
This is a neutral-to-slightly-positive disclosure for retail investors, as it confirms that promoters have not added new pledges on their holdings in the past year. No immediate share price impact is expected, and no action is required from shareholders.